Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFYVE19 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | SMIM22 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | EDDM3B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | SNRPA1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | PPT1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | NRBP1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | NAA35 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | FAM13C | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | EFCAB1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | GSTO2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |